Eyal Lifschitz

Eyal Lifschitz founded Bio Control Medical BCM Ltd. in 1999, VisionCare Ophthalmic Technologies Ltd. in 1997, Pharmasys Ltd. in 1990, Samsara Vision, Inc. in 1997, where he worked as Director-Business Development from 1997 to 2001, Electro-Chemical Research Ltd. in 1994, where he worked as General Manager in 2001, Biocontrol Ltd. (United Kingdom) in 1999, where he worked as Director-Business Development from 1999 to 2001, and Peregrine Ventures Management Ltd. in 2001, where he is working as Managing General Partner from 2010.
Mr. Lifschitz also founded Gam Vegam, where he worked as Chairman.
Mr. Lifschitz also currently works at Cordio Medical Ltd., as Chairman, Israel Early-Stage Investors Association, as Chairman, Neovasc Medical Ltd., as Director, N.L.T Spine Ltd., as Director, Valtech Cardio Ltd., as Director, KAHR Medical Ltd., as Director, Otic Pharma Ltd., as Director, Raziel Therapeutics RT Ltd., as Director from 2019, Peregrine VC Investments II (Israel) LP, as General Partner, and Peregrine Ventures Growth GP LP, as General Partner.
Mr. Lifschitz also formerly worked at Given Imaging Ltd., as Director, Given Imaging Ltd., as Director from 2003 to 2007, NeuroSonix Ltd., as Director, Neovasc, Inc., as Director from 2003 to 2007, ETV Energy Ltd., as Director, CardioGard Medical Ltd., as Director, Momentis Surgical Ltd., as Director, and Cardiovalve Ltd., as Director.
Mr. Lifschitz received his undergraduate degree from Bar-Ilan University.